Northwest Biotherapeutics completes direct public offering

Northwest Biotherapeutics Inc. (NASDAQ:NWBO), Bethesda, Md. Business: Cancer Date completed: 2015-12-24 Type: Direct public offering Raised: $12.6 million Shares: 3.5 million Price: $3.60 Shares after...